Friday, October 23, 2026

USD/EUR Went Down By Over 2% In The Last 21 Sessions

USD/EUR Went Down By Over 2% In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 2% for the last 21 sessions. At 09:09 EST on Thursday, 14 March, USD/EUR (USDEUR) is $0.92.

USD/EUR's yearly highs and lows, it's 3.18% up from its 52-week low and 4.378% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.07%, a negative 0.11%, and a positive 0.27%, respectively.

USD/EUR's highest amplitude of average volatility was 0.17% (last week), 0.19% (last month), and 0.27% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be oversold (<=20).

News about

  • Eur/usd price analysis: the bullish outlook remains intact above the 1.0900 mark. According to FXStreet on Tuesday, 12 March, "The EUR/USD pair gains momentum below the mid-1.0900s during the early European trading hours on Tuesday. ", " According to the four-hour chart, EUR/USD keeps the bullish vibe unchanged as the major pair is above the key 50- and 100-period Exponential Moving Averages (EMA) with an upward slope. "
  • According to FXStreet on Wednesday, 13 March, "At the time of writing, the EUR/USD pair is trading higher at 1.0927, gaining 0.01% on the day."
  • Eur/usd analysis: gains stall ahead of key US data - 12 March 2024. According to DailyForex on Tuesday, 12 March, "We tend to view the major moving averages as an indicator of where momentum is, and the EUR/USD price is sitting above the 50-, 100- and 200-day moving averages. ", "Only when the pair starts to fall below these levels will we put the EUR/USD rate on alert for a broader decline."
  • Eur/usd inches higher to near 1.0930, focus on US inflation data. According to FXStreet on Tuesday, 12 March, "A robust CPI report would likely dampen prospects of an imminent rate cut by the Federal Reserve (Fed), potentially strengthening the US Dollar (USD) and presenting challenges for the EUR/USD pair.", "The optimistic outlook surrounding the ECB could offer bolstering for the Euro, thereby supporting the EUR/USD pair. "
  • Eur/usd middled on Tuesday after mixed US CPI inflation print pins pair. According to FXStreet on Tuesday, 12 March, "The EUR/USD spent most of Tuesday cycling familiar territory, with the pair churning chart paper just north of 1.0900. ", "The EUR/USD set a fresh weekly high at 1.0980 on Monday, and the pair continues to see near-term technical support from a shortrun rising trendline."

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise Software Races to Govern and Consolidate Around Agentic AI
Enterprise software vendors are repositioning around autonomous AI agents. Salesforce is acquiring Braze, ServiceNow is launching agent governance tools (AI Passport, Super Intelligence Control Tower), SAP is pushing its 'Autonomous Enterprise', and Zeta is launching AthenaOS and its own inference model. Palantir is embedding itself in banking, aviation and sovereign AI infrastructure through partnerships with Customers Bank, Surf Air, Ondas and Armada. Governance, data sovereignty and enforced policy are emerging as preconditions for regulated sectors like finance. Investors such as Norwest see room to disrupt ERP and finance software, and they caution that AI should not be trusted with financial calculations. Consolidation and shareholder disputes (Salesforce/Braze, Tiny/Oso Cloud, ZenaTech/Boardwalktech) show the market reshaping.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,475 source documents archived
Query this data → isubstrate.com